Symmetry Partners, LLC Laboratory Corp Of America Holdings Transaction History

Symmetry Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	SELL	$197.69 - $227.29 $137,196 - $157,739	-694 Reduced 30.51%	1,581 $359,000
Q1 2022 Apr 04, 2022	SELL	$259.82 - $298.18 $107,825 - $123,744	-415 Reduced 15.43%	2,275 $600,000
Q4 2021 Jan 11, 2022	BUY	$271.6 - $314.21 $60,295 - $69,754	222 Added 9.0%	2,690 $845,000
Q4 2020 Feb 18, 2021	SELL	$186.91 - $214.42 $210,647 - $241,651	-1,127 Reduced 31.35%	2,468 $502,000
Q3 2020 Nov 03, 2020	BUY	$167.03 - $201.3 $600,472 - $723,673	3,595 New	3,595 $677,000
Q2 2019 Aug 07, 2019	SELL	$144.16 - $172.9 $116,913 - $140,221	-811 Closed	0 $0
Q4 2018 May 22, 2019	BUY	$120.82 - $174.09 $97,985 - $141,186	811 New	811 $396,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.